Advertisement
Screener

Anteris Technologies Global Corp. (AVR) EBITDA

Anteris Technologies Global Corp. (AVR) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$30.53M*; Operating income -$31.00M; Depreciation and amortization $469.00K*.
  • 2026-03-31: Basis Reported; EBITDA -$23.58M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$28.54M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$21.85M*; Operating income -$22.27M; Depreciation and amortization $417.00K*.

Complete source-backed ebitda history.

Available history
2024-03-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$30.53M*-$31.00M$469.00K*$1.01M-3025.57%*$648.00K*-$20.80M*$233.00K$23.37M$8.40M$0.00
2026-03-31Reported-$23.58M(m)(m)(m)-4772.87%$137.00K-$28.68M$114.00K$17.46M$6.93M$492.00K
2025-12-31Reported-$28.54M(m)(m)(m)-9207.10%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$21.85M*-$22.27M$417.00K*$429.00K-5092.77%*$772.00K*-$18.25M*$123.00K$16.81M$5.76M$0.00
2025-06-30Reported-$20.47M*-$20.88M$418.00K*$618.00K-3311.65%*$537.00K*-$19.54M*$148.00K$16.34M$5.01M$0.00
2025-03-31Reported-$21.38M(m)(m)(m)-3844.78%$248.00K-$21.49M$207.00K$16.46M$5.67M$0.00
2024-12-31Reported-$21.12M(m)(m)(m)-3939.37%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$20.22M*-$20.60M$381.00K*$769.00K-2628.87%*$540.00K*-$14.10M*$443.00K$13.95M$6.98M$0.00
2024-06-30Reported-$18.09M*-$18.47M$377.00K*$632.00K-2862.97%*$646.00K*-$13.37M*$312.00K$12.63M$6.16M$0.00
2024-03-31Reported-$17.44M(m)(m)(m)-2276.76%$717.00K-$15.53M$473.00K$11.56M$6.52M$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$92.23M(m)(m)(m)-4821.38%$1.95M-$77.80M$569.00K$69.12M$26.12M$0.00
2024-12-31Reported-$76.87M(m)(m)(m)-2843.69%$2.27M-$61.24M$1.44M$51.45M$28.19M$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enovis CORP (ENOV)United States$1.053B-1.18
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B